Placebo + Xolair
ApprovedUNKNOWN 0 views this week 0 watching💤 Quiet
Interest: 39/100
39
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Allergy
Conditions
Allergy
Trial Timeline
Jun 1, 2007 → Nov 1, 2012
NCT ID
NCT00673218About Placebo + Xolair
Placebo + Xolair is a approved stage product being developed by Novartis for Allergy. The current trial status is unknown. This product is registered under clinical trial identifier NCT00673218. Target conditions include Allergy.
What happened to similar drugs?
3 of 13 similar drugs in Allergy were approved
Approved (3) Terminated (3) Active (7)
Hype Score Breakdown
Clinical
20
Activity
4
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00673218 | Approved | UNKNOWN |
| NCT00691873 | Approved | Completed |
| NCT00139152 | Approved | Completed |
Competing Products
20 competing products in Allergy